Well - the best situation is if the FDA announcement comes mid to later in the trading day actually.
It is still unofficial but sure does seem like that Form 4 was a major tell. Should/will gap up but if there is no pre-market news release, then expect 60 cents at open and then when news does hit, we could see $1 real quick. Should run up to at least 1.40's before a sell off in early Feb.
They couldn't afford to lose Q2 of nasal allergy relief sales and I'm glad this won't happen. So 60 cents to a $1 or we could also see a trading HALT and when lifted it opens around $1. You will have some short covering and major players coming on in for a takeover play, which I do think will happen inside of 24 months ! The sheer future value of Fluticare makes this an awesome acquisition target by multiple players IMO. The BH platform has also proven to be a major driver - big success! Watch how many cross-sales happen from online nasal allergy relief buyers :) Last time I checked, they have sex, some have diabetes and low-T, and some are struggling with short-term memory issues and infertility/poor health.
Getting the word out and targeting those in need is so important. Be that product ambassador folks. Can't stress it enough
1M in revs at 8 cents PPS with 60'sM o/s and now we could see 29x the revenue for 2017 to 29M with o/s only doubling from 7 months ago!! My prediction is 1.18 - 1.22 range with a peak into the upper 1.40's. That is my best guesstimate
* Volume will be jaw dropping
News 
Market Data 
Discover 
AI
